72.17
Mirum Pharmaceuticals Inc stock is traded at $72.17, with a volume of 428.53K.
It is down -0.74% in the last 24 hours and down -2.88% over the past month.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
See More
Previous Close:
$72.71
Open:
$71.92
24h Volume:
428.53K
Relative Volume:
0.60
Market Cap:
$3.63B
Revenue:
$379.25M
Net Income/Loss:
$-77.34M
P/E Ratio:
-44.76
EPS:
-1.6122
Net Cash Flow:
$-27.87M
1W Performance:
-0.50%
1M Performance:
-2.88%
6M Performance:
+82.34%
1Y Performance:
+79.93%
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Name
Mirum Pharmaceuticals Inc
Sector
Industry
Phone
650-667-4085
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Compare MIRM with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MIRM
Mirum Pharmaceuticals Inc
|
72.17 | 3.65B | 379.25M | -77.34M | -27.87M | -1.6122 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-24-25 | Initiated | TD Cowen | Buy |
Aug-11-25 | Resumed | Stifel | Buy |
May-19-25 | Resumed | H.C. Wainwright | Buy |
Apr-17-24 | Initiated | Stifel | Buy |
Dec-18-23 | Reiterated | H.C. Wainwright | Buy |
Nov-20-23 | Resumed | JP Morgan | Overweight |
Nov-13-23 | Initiated | Morgan Stanley | Overweight |
Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
Oct-17-23 | Resumed | Evercore ISI | Outperform |
Sep-20-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-01-22 | Initiated | Citigroup | Buy |
Sep-20-21 | Initiated | JP Morgan | Overweight |
Aug-07-20 | Upgrade | Raymond James | Outperform → Strong Buy |
Aug-03-20 | Initiated | H.C. Wainwright | Buy |
Jul-31-20 | Initiated | Piper Sandler | Overweight |
Jun-25-20 | Initiated | Robert W. Baird | Outperform |
Aug-12-19 | Initiated | Citigroup | Buy |
Aug-12-19 | Initiated | Evercore ISI | Outperform |
Aug-12-19 | Initiated | Guggenheim | Buy |
Aug-12-19 | Initiated | ROTH Capital | Buy |
Aug-12-19 | Initiated | Raymond James | Outperform |
View All
Mirum Pharmaceuticals Inc Stock (MIRM) Latest News
Why Mirum Pharmaceuticals Inc. stock remains undervalued2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
Technical signs of recovery in Mirum Pharmaceuticals Inc.Weekly Profit Summary & Stepwise Trade Execution Plans - newser.com
How to build a custom watchlist for Mirum Pharmaceuticals Inc.Trade Volume Summary & Safe Capital Investment Plans - newser.com
Is it time to cut losses on Mirum Pharmaceuticals Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsProduct Launch & Real-Time Chart Pattern Alerts - newser.com
Volume spikes in Mirum Pharmaceuticals Inc. stock – what they mean2025 Trade Ideas & Verified Short-Term Plans - newser.com
How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 6.9%Should You Buy? - MarketBeat
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal
Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com
Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in
Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com
Branded Website for Consumers 2025 - Medical Marketing and Media
Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com
Mirum Pharmaceuticals stock hits all-time high at 78.23 USD By Investing.com - Investing.com Australia
What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com
Custom watchlist performance reports with Mirum Pharmaceuticals Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Is Mirum Pharmaceuticals Inc. stock near bottom after declineDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
Why Mirum Pharmaceuticals Inc. (08D) stock is listed among top recommendationsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
How sentiment analysis helps forecast Mirum Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com
Identifying reversal signals in Mirum Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Is Mirum Pharmaceuticals Inc. forming a bottoming baseQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com
Price action breakdown for Mirum Pharmaceuticals Inc.Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Mirum Pharmaceuticals Inc Stock (MIRM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mirum Pharmaceuticals Inc Stock (MIRM) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Brege Laura | Director |
Sep 11 '25 |
Sale |
74.40 |
17,000 |
1,264,868 |
15,703 |
BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER |
Sep 12 '25 |
Sale |
76.01 |
9,578 |
728,024 |
39,945 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):